peptide t has been researched along with Palmoplantaris Pustulosis in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.76) | 18.7374 |
| 1990's | 12 (70.59) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 1 (5.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baroni, A; De Gregorio, V; Donnarumma, G; Paoletti, I; Perez, JJ; Tufano, MA | 1 |
| Marcusson, JA; Rozell, BL; Sundqvist, KG; Talme, T; Wetterberg, L | 1 |
| Hilliges, M; Johansson, O; Marcusson, JA; Talme, T; Wang, L; Wetterberg, L | 1 |
| Hilliges, M; Johansson, O; Marcusson, JA; Talme, T; Wetterberg, L | 2 |
| Hilliges, M; Johansson, O; Lund-Rosell, B; Marcusson, JA; Sundquist, KG; Talme, T; Wetterberg, L | 1 |
| Anderson, WB; Evain-Brion, D; Liapi, C; Raynaud, F; Takahashi, N | 1 |
| Farber, EM; Raychaudhuri, SK; Raychaudhuri, SP | 2 |
| Farber, EM; Raychaudhuri, SP | 1 |
| Barbagallo, J; Kagen, MH; Tutrone, WD; Weinberg, JM | 1 |
| Brunetti, B; Delfino, M; Fabbrocini, G; Procaccini, EM; Santoianni, P | 1 |
| Dhiver, C; Gastaut, JA; Mawas, C; Olive, D; Poizot-Martin, I | 1 |
| Johansson, O; Marcusson, JA; Talme, T; Wetterberg, L | 1 |
| Cohen, EN; Farber, EM; Trozak, DJ; Wilkinson, DI | 1 |
| Marcusson, JA; Wetterberg, L | 1 |
| Lazega, D; Marcusson, JA; Pert, CB; Ruff, MR; Sundquist, KG; Wetterberg, L | 1 |
2 review(s) available for peptide t and Palmoplantaris Pustulosis
| Article | Year |
|---|---|
Speculations around the mechanism behind the action of peptide T in the healing of psoriasis: a minireview.
Topics: Amino Acid Sequence; Humans; Molecular Sequence Data; Peptide T; Psoriasis; Vasoactive Intestinal Peptide | 1993 |
Biologic therapy for psoriasis: a brief history, I.
Topics: Antibodies; Antibodies, Monoclonal; Biological Therapy; CD4 Antigens; Clinical Trials as Topic; Exotoxins; Humans; Immunotherapy; Immunotoxins; Peptide T; Psoriasis; Treatment Outcome | 2001 |
3 trial(s) available for peptide t and Palmoplantaris Pustulosis
| Article | Year |
|---|---|
Anti-chemotactic activities of peptide-T: a possible mechanism of actions for its therapeutic effects on psoriasis.
Topics: Adult; Chemokine CCL5; Chemotaxis, Leukocyte; Female; Humans; Male; Middle Aged; Monocytes; Peptide T; Psoriasis; T-Lymphocytes | 1998 |
Peptide T a new treatment for psoriasis? A study of nine patients.
Topics: Adult; Aged; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Peptide T; Psoriasis | 1991 |
Peptide T improves psoriasis when infused into lesions in nanogram amounts.
Topics: Adult; Biopsy; Double-Blind Method; Equipment Design; Female; Humans; Infusion Pumps; Injections, Intralesional; Male; Middle Aged; Peptide T; Placebos; Psoriasis; Sodium Chloride; Time Factors | 1991 |
12 other study(ies) available for peptide t and Palmoplantaris Pustulosis
| Article | Year |
|---|---|
Amygdalin analogues inhibit IFN-γ signalling and reduce the inflammatory response in human epidermal keratinocytes.
Topics: Amygdalin; Antineoplastic Agents, Phytogenic; Enzyme Inhibitors; HSP70 Heat-Shock Proteins; Humans; Inflammation; Intercellular Adhesion Molecule-1; Interferon-gamma; Interleukin-23; Interleukin-6; Interleukin-8; Keratinocytes; Nitriles; Peptide T; Psoriasis; Signal Transduction; STAT3 Transcription Factor; Tumor Necrosis Factor-alpha | 2013 |
Histopathological and immunohistochemical changes in psoriatic skin during peptide T treatment.
Topics: Antigens, CD1; Biopsy; Humans; Immunohistochemistry; Injections, Intravenous; Langerhans Cells; Lymphocytes; Peptide T; Psoriasis | 1995 |
Rearrangement of S-100 immunoreactive Langerhans' cells in human psoriatic skin treated with peptide T.
Topics: Adult; Female; Humans; Immunohistochemistry; Langerhans Cells; Male; Peptide T; Psoriasis; S100 Proteins; Skin | 1995 |
Somatostatin immunoreactive cells in lesional psoriatic human skin during peptide T treatment.
Topics: Adult; Aged; Dendritic Cells; Female; Humans; Immunohistochemistry; Male; Middle Aged; Peptide T; Psoriasis; Skin; Somatostatin | 1994 |
Peptide T: a new treatment for psoriasis? A review of our experiences.
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Peptide T; Psoriasis | 1994 |
Effects of [D-Ala1] peptide T-NH2 and HIV envelope glycoprotein gp120 on cyclic AMP dependent protein kinases in normal and psoriatic human fibroblasts.
Topics: Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Fibroblasts; HIV Envelope Protein gp120; Humans; Peptide T; Psoriasis; Reference Values; Skin | 1998 |
Immunomodulatory effects of peptide T on Th 1/Th 2 cytokines.
Topics: Adjuvants, Immunologic; Adult; Cytokines; Female; Humans; In Vitro Techniques; Interferon-gamma; Interleukin-10; Leukocytes, Mononuclear; Male; Middle Aged; Peptide T; Psoriasis | 1999 |
Neuroimmunologic aspects of psoriasis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Biphenyl Compounds; Humans; Immunohistochemistry; Inflammation; Injections, Intralesional; Nerve Growth Factor; Neuroimmunomodulation; Neuropeptides; Peptide T; Psoriasis; Psychoneuroimmunology; Receptors, Nerve Growth Factor; Relaxation Therapy; Skin; Stress, Psychological; Substance P | 2000 |
Peptide T in the treatment of severe psoriasis.
Topics: Adult; CD4-CD8 Ratio; Humans; Middle Aged; Peptide T; Psoriasis; Severity of Illness Index | 1992 |
Are CD4 antibodies and peptide T new treatments for psoriasis?
Topics: Adult; Antibodies, Monoclonal; CD4 Antigens; HIV Seropositivity; HIV-1; Humans; Male; Peptide T; Psoriasis | 1991 |
Peptide-T in the treatment of psoriasis and psoriatic arthritis. A case report.
Topics: Arthritis; Humans; Male; Middle Aged; Oligopeptides; Peptide T; Psoriasis | 1989 |
Peptide T and psoriasis.
Topics: Adult; Biopsy; HIV Seropositivity; Humans; Infusions, Intravenous; Male; Peptide T; Psoriasis; Time Factors | 1989 |